| Alzheimer's disease (1) |  |
| Brain damage (2) | |
| Epilepsy (1) | |
| Meningitis (1) | |
| Paralysis (4) | |
| Parkinson's disease (3) | |
| Alzheimer's disease (1) | |
| Brain damage (2) | |
| Epilepsy (1) | |
| Meningitis (1) | |
| Paralysis (4) | |
| Parkinson's disease (3) | |
leading to the rapid synthesis of drug derivatives for treating Parkinson's disease. Nagoya, Japan-Yutaro Saito, Yasutomo Segawa and Professor Kenichiro Itami at the Institute of Transformative Biomolecules (ITBM
which is an anticholinergic drug used in the treatment of Parkinson's disease.''Parachuting'boron onto the para-position of a benzene ring by a bulky iridium catalyst.
Caramiphen, an anticholinergic agent used for the treatment of Parkinson's disease contains a monosubstituted benzene moiety along with ester and amine groups.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011